These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21883992)

  • 1. Interventional treatments for hypertrophic cardiomyopathy.
    Mohiddin SA; Knight C
    Cardiovasc Ther; 2012 Jun; 30(3):e107-14. PubMed ID: 21883992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does myectomy convey survival benefit in hypertrophic cardiomyopathy?
    Woo A; Rakowski H
    Heart Fail Clin; 2007 Jul; 3(3):275-88. PubMed ID: 17723936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertrophic cardiomyopathy in 2013].
    Giannakopoulos G; Frangos C
    Rev Med Suisse; 2013 Mar; 9(376):502, 504-7. PubMed ID: 23534110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. My approach to clinical management of hypertrophic cardiomyopathy.
    Maron MS
    Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674
    [No Abstract]   [Full Text] [Related]  

  • 5. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
    Elliott PM; Gimeno JR; Tomé MT; Shah J; Ward D; Thaman R; Mogensen J; McKenna WJ
    Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertrophic cardiomyopathy: current aspects and new developments].
    Desnos M
    Bull Acad Natl Med; 2012; 196(4-5):997-1009; discussion 1009-10. PubMed ID: 23550458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic obstructive cardiomyopathy: review of surgical treatment.
    Price J; Clarke N; Turer A; Quintana E; Mestres C; Huffman L; Peltz M; Wait M; Ring WS; Jessen M; Bajona P
    Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):594-607. PubMed ID: 28901158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy.
    Sasson Z; Rakowski H; Wigle ED
    Cardiol Clin; 1988 May; 6(2):233-88. PubMed ID: 3066484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future.
    Ommen SR; Shah PM; Tajik AJ
    Heart; 2008 Oct; 94(10):1276-81. PubMed ID: 18653577
    [No Abstract]   [Full Text] [Related]  

  • 11. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
    ; Elliott PM; Anastasakis A; Borger MA; Borggrefe M; Cecchi F; Charron P; Hagege AA; Lafont A; Limongelli G; Mahrholdt H; McKenna WJ; Mogensen J; Nihoyannopoulos P; Nistri S; Pieper PG; Pieske B; Rapezzi C; Rutten FH; Tillmanns C; Watkins H
    Eur Heart J; 2014 Oct; 35(39):2733-79. PubMed ID: 25173338
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy: individualized therapy for a heterogeneous disease.
    Sherrid MV; Sirak T
    Minerva Cardioangiol; 2008 Dec; 56(6):671-92. PubMed ID: 19092743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A patient with aortic valve stenosis and severe obstruction of the left ventricular outflow tract: a diagnostic challenge].
    Nentwich K; Flachskampf FA
    Dtsch Med Wochenschr; 2010 May; 135(20):1016-9. PubMed ID: 20461658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy and risk-stratification in hypertrophic cardiomyopathy--a current survey].
    Reith S; Klues HG
    Z Kardiol; 2003 Apr; 92(4):283-93. PubMed ID: 12707787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
    McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
    Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.
    Shah JS; Esteban MT; Thaman R; Sharma R; Mist B; Pantazis A; Ward D; Kohli SK; Page SP; Demetrescu C; Sevdalis E; Keren A; Pellerin D; McKenna WJ; Elliott PM
    Heart; 2008 Oct; 94(10):1288-94. PubMed ID: 18032461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Takotsubo cardiomyopathy in a patient with previously undiagnosed hypertrophic cardiomyopathy with obstruction.
    Brabham WW; Lewis GF; Bonnema DD; Nielsen CD; O'Brien TX
    Cardiovasc Revasc Med; 2011; 12(1):70.e1-5. PubMed ID: 21036671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hypertrophic cardiomyopathy.
    Enriquez AD; Goldman ME
    Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary treatment of hypertrophic cardiomyopathy.
    Marian AJ
    Tex Heart Inst J; 2009; 36(3):194-204. PubMed ID: 19568388
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment.
    Ball W; Ivanov J; Rakowski H; Wigle ED; Linghorne M; Ralph-Edwards A; Williams WG; Schwartz L; Guttman A; Woo A
    J Am Coll Cardiol; 2011 Nov; 58(22):2313-21. PubMed ID: 22093509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.